Form 4: Oncocyte Corp: Director Patrick W. Smith Increases Stake in OCX

Patrick W. Smith, a director of Oncocyte Corp, reports acquiring additional shares of common stock through private placements and registered direct offerings.

Summary

• On February 7, 2025, Patrick W. Smith, a director of Oncocyte Corp, acquired 1,077,600 shares of common stock at $2.05 per share through a private placement.
• On the same date, Smith also acquired 385,814 shares at $2.05 per share through a registered direct offering.
• Following these transactions, Smith's total indirect beneficial ownership increased to 3,258,485 shares held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015.
• Smith may be deemed to beneficially own the securities held by the Trust as the trustee.

Sentiment

Score: 6

Explanation: Director increasing stake is generally positive, but the need for private placements and registered direct offerings could indicate a need for capital.

Positives

• A director increasing their stake in the company can be seen as a positive signal.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's prospects.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive signal.
• The capital raise could dilute existing shareholders.

Key Dates